Growth Metrics

Zymeworks (ZYME) Tax Provisions (2021 - 2026)

Zymeworks recorded quarterly Tax Provisions of -$2.2 million in Q1 2026, down 711.48% quarter-over-quarter from -$270000.0 in Q4 2025, and down 541.73% year-over-year from $496000.0 in Q1 2025.

Zymeworks' Tax Provisions history runs 6 years deep, the most recent figure standing at -$2.2 million for Q1 2026.

  • In Q1 2026, Tax Provisions fell 541.73% year-over-year to -$2.2 million; the TTM figure through Mar 2026 stood at -$1.3 million (down 120.15% YoY), while the FY2025 annual figure was $1.4 million, down 77.38% from the prior year.
  • Tax Provisions came in at -$2.2 million for Q1 2026 at Zymeworks, down from -$270000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $11.0 million in Q4 2022 to a low of -$4.7 million in Q4 2023.
  • A 5-year average of $917294.1 and a median of $75000.0 in 2024 frame the typical range for Tax Provisions.
  • Across the five-year window, Tax Provisions jumped 18477.78% in 2023 and sank 541.73% in 2026, its largest moves.
  • Zymeworks' Tax Provisions stood at $11.0 million in 2022, then plunged by 142.91% to -$4.7 million in 2023, then jumped by 221.03% to $5.7 million in 2024, then slumped by 104.72% to -$270000.0 in 2025, then slumped by 711.48% to -$2.2 million in 2026.
  • According to Business Quant data, Tax Provisions over the past three periods registered -$2.2 million, -$270000.0, and $1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -11.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -859,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 221.50 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - 216,000.00
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 104.00 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 15.66 Mn
10 Zymeworks 1.84 Bn 1.47 Bn - -2.19 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -2.19 Mn
Dec 31, 2025 -270,000.00
Sep 30, 2025 1.34 Mn
Jun 30, 2025 -186,000.00
Mar 31, 2025 496,000.00
Dec 31, 2024 5.72 Mn
Sep 30, 2024 226,000.00
Jun 30, 2024 68,000.00
Mar 31, 2024 75,000.00
Dec 31, 2023 -4.72 Mn
Sep 30, 2023 1.11 Mn
Jun 30, 2023 1.65 Mn
Mar 31, 2023 1.39 Mn
Dec 31, 2022 11.01 Mn
Sep 30, 2022 -29,000.00
Jun 30, 2022 -9,000.00
Mar 31, 2022 -74,000.00
Dec 31, 2021 -1.37 Mn
Sep 30, 2021 764,000.00